Karyopharm Therapeutics, Inc. (KPTI)
0.4244
+0.07
(+18.35%)
USD |
NASDAQ |
Oct 21, 16:00
0.43
+0.01
(+1.32%)
After-Hours: 04:38
Karyopharm Therapeutics Net Income (Annual) : -196.04M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -196.04M |
| December 31, 2024 | -76.42M |
| December 31, 2023 | -143.10M |
| December 31, 2022 | -165.29M |
| December 31, 2021 | -124.09M |
| December 31, 2020 | -196.27M |
| December 31, 2019 | -199.59M |
| December 31, 2018 | -178.41M |
| Date | Value |
|---|---|
| December 31, 2017 | -128.98M |
| December 31, 2016 | -109.58M |
| December 31, 2015 | -118.18M |
| December 31, 2014 | -75.78M |
| December 31, 2013 | -33.95M |
| December 31, 2012 | -15.89M |
| December 31, 2011 | -10.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -288.28M |
| Relay Therapeutics, Inc. | -276.48M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |